As of November 2026 Orchestra BioMed has a market cap of โน53.77 Billion. This makes Orchestra BioMed the world's 7324th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Nov 13th, 2026 the market cap of Orchestra BioMed was reported to be: